VCN BIOSCIENCES SL focuses in the development of new therapeutic approaches for tumors that lack effective treatment. The company uses an oncolytic adenovirus technology platform to design highly selective and efficient agents that replicate and self-amplify exclusively in tumor cells.
Products, services and capacities
Cancer treatment development
Health & Healthcare Services
Activity classification (NACE)
8030 - Investigation activities
7211 - Research and experimental development on biotechnology